<DOC>
	<DOCNO>NCT01920815</DOCNO>
	<brief_summary>In order determine effectiveness medical therapy option prevent enlargement aorta patient bicuspid aortic valve , randomize study plan . This feasibility study gather accurate data number need screen , change medication use time , variance intend study endpoint .</brief_summary>
	<brief_title>Bicuspid Valve Aortopathy Feasibility Study</brief_title>
	<detailed_description>The study consider patient bicuspid aortic valve 1 ) determine number patient need screened clinical trial , base patient eligibility percentage apply specific inclusion exclusion criterion , 2 ) meeting criterion , follow change compliance medical therapy two year , 3 ) limit subset eligible patient , perform MRI baseline 2 year measure change aortic area time .</detailed_description>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Bicuspid aortic valve Aortic measurement 35 49 mm prior image study Prior aortic valve thoracic aortic surgery Prior aortic dissection Other condition associate enlarge aorta include Coarctation , Marfans , Turner syndrome , LoeysDietz , etc . Severe aortic stenosis regurgitation Contraindication MRI claustrophobia implant pacer/defibrillator Anticipated pregnancy , surgery , move outside area within 2 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>